RVL Pharmaceuticals, Inc.
10 clinical trials · Sponsor
◉ Watch RVL Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis (NCT03565887) | RVL Pharmaceuticals, Inc. | 2018-06-28 |
| Study of Safety of RVL-1201 in Treatment of Blepharoptosis (NCT03536949) | RVL Pharmaceuticals, Inc. | 2018-06-20 |
| A Study to Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MS (NCT03319732) | RVL Pharmaceuticals, Inc. | 2018-04-03 |
| A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MS (NCT03290131) | RVL Pharmaceuticals, Inc. | 2018-01-28 |
Track RVL Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.